Komen awards grant to UT researchers studying drug-resistant breast cancer

Komen awards grant to UT researchers studying drug-resistant breast cancer
(Source: WTOL)

TOLEDO, OH (WTOL) - It's right there in the title "Race for the CURE."

Your race registrations not only help people battling cancer right now. They also fund research. You can register for the race here.

Triple Negative Breast cancer is the focus of research in Dr. Amit Tiwari's lab at the University of Toledo. It's the most aggressive form of breast cancer because it's resistant to treatment, which causes it to spread.

His team had made a major breakthrough.

"Recently, we discovered a molecule that can actually target these drug-resistant tumors. Not only can they reverse the drug-resistance, when you combine the original chemotherapy, they are more responsive," said Dr. Tiwari.

Dr. Tiwari and his team patented the drug and with a $450,000 gr ant from Susan G. Komen of Northwest Ohio, they'll use it first on mice. What comes next is what's most exciting.

"We test these compounds at pre-clinical station and try to bring it to clinical trials," said Dr. Tiwari.

He added, in three to five years, the drug may be ready to start treating breast cancer patients facing the most grim prognoses.

It's thanks to your support through the Race for the Cure in just the past two years.

"That money and that time and that effort you spent to come and be part of this is now bearing fruit in the research of Dr. Tiwari and it's incredible," said Desmond Strooh with Susan G. Komen of Northwest Ohio.

If you've ever been on the fence about getting involved, you can rest-assured your contribution is truly funding the goal of finding a cure, right here in Toledo.

Copyright 2018 WTOL. All rights reserved.